Prior to 2009, Hycult Biotech b.v. had been using a U.S.- based reseller partner for over 9 years. Over time Wim de Niet, Founder and Owner of Hycult began to identify behaviors by the distributor that did not align with the distribution agreement and Hycult Biotech’s growth ambition.
In October of 2009, Percorso Life Sciences incorporated Hycult Biotech Inc. in the U.S. and began to operate the subsidiary on behalf of the parent company. Fast forward to today: Percorso is still operating the subsidiary on behalf of the parent and allocates 2 FTE to their operations. The end result is the U.S. subsidiary has grown at an average 10% CAGR since 2010, grew its direct (b.v. recognized) OEM business, and introduced a new custom services business Biocult b.v. in the country. Dino DiCamillo has a seat on the Board of Hycult and continues to work with Ronald de Niet, the current CEO and Owner of Hycult Biotech b.v. on a number of projects.
Percorso’s logistics services (bulk import, warehousing, and order fulfillment) have enabled continuous growth and minimized the cost of serving US customers.
